Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.

MLA

Joly-Guillou, Marie-Laure, et al. “Comparative in Vitro Activity of Meropenem, Imipenem and Piperacillin/Tazobactam against 1071 Clinical Isolates Using 2 Different Methods: A French Multicentre Study.” BMC Infectious Diseases, vol. 10, Mar. 2010, p. 72. EBSCOhost, https://doi.org/10.1186/1471-2334-10-72.

APA

Joly-Guillou, M.-L., Kempf, M., Cavallo, J.-D., Chomarat, M., Dubreuil, L., Maugein, J., Muller-Serieys, C., & Roussel-Delvallez, M. (2010). Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study. BMC Infectious Diseases, 10, 72. https://doi.org/10.1186/1471-2334-10-72

Chicago

Joly-Guillou, Marie-Laure, Marie Kempf, Jean-Didier Cavallo, Monique Chomarat, Luc Dubreuil, Jeanne Maugein, Claudette Muller-Serieys, and Micheline Roussel-Delvallez. 2010. “Comparative in Vitro Activity of Meropenem, Imipenem and Piperacillin/Tazobactam against 1071 Clinical Isolates Using 2 Different Methods: A French Multicentre Study.” BMC Infectious Diseases 10 (March): 72. doi:10.1186/1471-2334-10-72.